|
시장보고서
상품코드
2050459
바이오버든 시험 시장 : 제품별, 시험 유형별, 용도별, 최종사용자별, 지역별Bioburden Testing Market, By Product, By Test Type, By Application, By End User, By Geography |
||||||
바이오버든 검사 시장은 2026년에 15억 3,000만 달러로 추계되고 있으며, 2033년까지 29억 1,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 9.6%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 15억 3,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 9.60% | 2033년 시장 규모 예측 : | 29억 1,000만 달러 |
바이오버든 테스트는 제품, 원료 또는 표면에 존재하는 미생물의 검출 및 정량화를 말합니다. 바이오버든 테스트는 제조에 사용되는 재료와 장비가 적절한 위생 기준을 충족하는지 확인함으로써 의약품 및 헬스케어 제품의 품질관리에 도움이 됩니다. 또한 무균 상태의 유지와 무균 의료기기, 설비, 완제품의 오염 방지에 중요한 역할을 하고 있습니다. 바이오버든 시험 시장은 의료기기 시험을 의무화하는 엄격한 규제, 수탁제조기관(CMO)의 보급 확대, 의약품 제조의 아웃소싱 증가로 인해 성장하고 있습니다. 의료기기나 의약품은 환자와 직접적으로 연관되어 있으므로 무균 상태 유지와 미생물 증식 방지가 매우 중요합니다. 바이오버든 테스트는 멸균 공정의 유효성을 확인하고, 제조 및 운송 중 혼입될 수 있는 오염물질을 검출하기 위한 품질관리 수단을 제공합니다. 이러한 테스트 결과는 적절한 보관 기간을 결정하는 데 도움이 되며, 향후 제품 로트에 문제가 발생했을 때 이를 조사하는 데도 도움이 됩니다.
시장 역학
세계의 바이오버든 테스트 시장은 의약품 및 의료기기 제조에서 바이오버든 테스트에 대한 엄격한 규제 요건에 의해 주도되고 있습니다. 미국 식품의약국(FDA), 유럽의약품청(EMA) 등 규제 당국은 비멸균 제품의 안전성과 유효성을 보장하기 위해 다양한 단계에서 바이오버든 테스트를 의무화하고 있습니다. 제약 및 의료기기 산업의 성장도 바이오버든 시험에 대한 수요를 촉진하고 있습니다. 그러나 바이오버든 테스트 장비와 서비스에 소요되는 높은 비용이 이 시장의 성장을 제한하고 있습니다. 신속한 자동 바이오버든 테스트 솔루션의 등장은 결과의 신속성과 처리 능력의 향상을 가능케 함으로써 큰 비즈니스 기회를 가져오고 있습니다. 제조 공정에서 바이오버든 테스트를 위한 연속 모니터링 시스템의 도입은 향후 수년간 더 많은 기회를 제공할 것입니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 매출기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계의 바이오버든 테스트 시장의 주요 기업 개요을 작성했습니다. 구체적으로는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 이 세계의 바이오버든 테스트 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 개요
제3장 시장 역학·규제·동향 분석
제4장 바이오버든 시험 시장 : 제품별, 2021-2033년
제5장 바이오버든 시험 시장 : 테스트 유형별, 2021-2033년
제6장 바이오버든 시험 시장 : 용도별, 2021-2033년
제7장 바이오버든 시험 시장 : 최종 사용별, 2021-2033년
제8장 바이오버든 시험 시장 : 지역별, 2021-2033년
제9장 기업 개요 : 바이오버든 시험 시장
제10장 참고 문헌 및 조사 방법
KSA 26.06.09Bioburden Testing Market is estimated to be valued at USD 1.53 Bn in 2026 and is expected to reach USD 2.91 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1.53 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.60% | 2033 Value Projection: | USD 2.91 Bn |
Bioburden testing refers to the detection and quantification of microorganisms present in or on a product, raw material, or surface. Bioburden testing helps monitor the quality of pharmaceutical and healthcare products by ensuring materials and equipment used in production meet appropriate hygienic standards. It plays a key role in maintaining sterility and preventing contamination of sterile devices, equipment, and finished products. The bioburden testing market is growing due to stringent regulations mandating testing of medical devices, rising penetration of contract manufacturing organizations, and increasing outsourcing of pharmaceutical manufacturing. As medical devices and pharmaceuticals are intended to interact directly with patients, maintaining sterility and preventing microbial growth are critical. Bioburden testing provides quality control measures to validate sterilization processes and detect any contaminants that may have been introduced during manufacturing or shipping. The results of these tests help determine appropriate shelf life and assist in investigations should any issues arise with a product batch in the future.
Market Dynamics
The global bioburden testing market is driven by stringent regulatory mandates for the testing of bioburden in pharmaceutical and medical device manufacturing. Regulatory agencies like the Food and Drug Administration. FDA and European Medicines Agency EMA require bioburden testing at various stages to ensure the safety and efficacy of non-sterile products. The growth in pharmaceutical and medical device industries has also fueled the demand for bioburden testing. However, the high costs associated with bioburden testing equipment and services limit the growth of this market. The emergence of rapid automated bioburden testing solutions presents lucrative opportunities, as they enable faster results and higher throughput. The adoption of continuous monitoring systems for bioburden testing during manufacturing further offers opportunities in the coming years.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global bioburden testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Charles River Laboratories, Merck KGaA, SGS, WuXi AppTec, and Becton, Dickinson and Company ,North American Science Associates Inc. , Nelson Laboratories LLC , Biomerieux SA ,Thermo Fisher ScientifiC and Pacific Biolabs.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global bioburden testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
- Bioburden Testing Market,By Product (Revenue, USD Bn, 2021 - 2033)
- Consumables
- Culture Media
- Reagents and Kits
- Instruments
- Automated Microbial Identification Systems
- PCR Instruments
- Bioburden Testing Market, By Test Type (Revenue, USD Bn, 2021 - 2033)
- Aerobic Count Testing
- Anaerobic Count Testing
- Fungi/Mold Count Testing
- Spore Count Testing
- Bioburden Testing Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Raw Material Testing
- Medical Device Testing
- In-Process Material Testing
- Sterilization Validation Testing
- Equipment Cleaning Validation
- Bioburden Testing Market, By End Use (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical & Biotechnology Companies
- Medical Device Manufacturers
- Contract Manufacturing Organizations
- Manufacturers of Food & Beverage and Agricultural Products
- Microbial Testing Laboratories
- Bioburden Testing Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top Companies in the Bioburden Testing Market
- Charles River Laboratories International Inc.
- SGS SA
- Merck KGaA
- Becton
- Dickinson and Company
- Wuxi Apptec
- North American Science Associates Inc.
- Nelson Laboratories LLC
- Biomerieux SA,
- Thermo Fisher Scientific
- Pacific Biolabs.
Table of Content
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Bioburden Testing Market, By Product
- Bioburden Testing Market, By Test Type
- Bioburden Testing Market, By Application
- Bioburden Testing Market, By End Use
- Bioburden Testing Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Bioburden Testing Market, By Product, 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast, 2021 - 2033, (USD Bn)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Consumables, 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Culture Media, 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Reagents and Kits, 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Instruments, 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Automated Microbial Identification System, 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- PCR Instruments, 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Bioburden Testing Market, By Test Type, 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast, 2021 - 2033, (USD Bn)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Aerobic Count Testing, 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Anaerobic Count Testing, 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Fungi/Mold Count Testing, 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Spore Count Testing, 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Bioburden Testing Market, By Application, 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast, 2021 - 2033, (USD Bn)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Raw Material Testing, 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Medical Device Testing, 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- In-process Material Testing, 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Sterilization Validation Testing, 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecas and Y-o-Y Growth t, 2021 - 2033, (USD Bn)
- Equipment Cleaning Validation, 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Bioburden Testing Market, By End Use, 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast, 2021 - 2033, (USD Bn)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Pharmaceutical & Biotechnology Companies , 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast, 2021 - 2033, (USD Bn)
- Medical Device Manufacturers , 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth 2021 - 2033, (USD Bn)
- Contract Manufacturing Organizations , 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Manufacturers Of Food & Beverage And Agricultural Products , 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Microbial Testing Laboratories, 2021 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Bioburden Testing Market, By Region, 2021 - 2033 (USD Bn)
- Introduction
- Market Share Analysis, 2021 - 2033, (USD Bn)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- By Region
- Introduction
- Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- North America
- Introduction
- Market Size and Forecast and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast and Y-o-Y Growth, By End Use, 2021 - 2033, (USD Bn)
- Market Size and Forecast and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast and Y-o-Y Growth, By End Use, 2021 - 2033, (USD Bn)
- Market Size and Forecas and Y-o-Y Growth t, By Country, 2021 - 2033, (USD Bn)
- U.K
- German
- Italy
- France
- Spain
- Russia
- Rest Of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast and Y-o-Y Growth, By End Use, 2021 - 2033, (USD Bn)
- Market Size and Forecast and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- Asean
- Rest Of Asia Pacific
- Middle East & Africa
- Introduction
- Market Size and Forecast, By Product and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End Use and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest Of Middle East
- Latin America
- Introduction
- Market Size and Forecast and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast and Y-o-Y Growth, By End Use, 2021 - 2033, (USD Bn)
- Market Size and Forecast and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
9. Company Profiles - Bioburden Testing Market
- Charles River Laboratories International, Inc.
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
- SGS SA
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
- Merck KGaA
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
- Becton
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
- Dickinson and Company
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
- Wuxi Apptec
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
- North American Science Associates Inc.
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
- Nelson Laboratories, LLC
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
- Biomerieux SA
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
- Thermo Fisher Scientific
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
- Pacific Biolabs
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
10. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
